
Wayne A. Langel
Examiner (ID: 12842, Phone: (571)272-1353 , Office: P/1736 )
| Most Active Art Unit | 1103 |
| Art Unit(s) | 2899, 1793, 1736, 1206, 1103, 1754 |
| Total Applications | 5015 |
| Issued Applications | 3911 |
| Pending Applications | 339 |
| Abandoned Applications | 795 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18260625
[patent_doc_number] => 11608319
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-21
[patent_title] => Beta-amino acid derivative, kinase inhibitor and pharmaceutical composition containing the same, and method for performing an in vivo related application that benefits from the inhibition of a kinase
[patent_app_type] => utility
[patent_app_number] => 17/117615
[patent_app_country] => US
[patent_app_date] => 2020-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 13
[patent_no_of_words] => 17287
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17117615
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/117615 | Beta-amino acid derivative, kinase inhibitor and pharmaceutical composition containing the same, and method for performing an in vivo related application that benefits from the inhibition of a kinase | Dec 9, 2020 | Issued |
Array
(
[id] => 20357284
[patent_doc_number] => 12473267
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-18
[patent_title] => Process and intermediate for the preparation of oxetan-2-yl-methanamine
[patent_app_type] => utility
[patent_app_number] => 17/779447
[patent_app_country] => US
[patent_app_date] => 2020-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2419
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17779447
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/779447 | Process and intermediate for the preparation of oxetan-2-yl-methanamine | Dec 6, 2020 | Issued |
Array
(
[id] => 16726570
[patent_doc_number] => 20210093717
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => BENZAMIDE AND ACTIVE COMPOUND COMPOSITIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/110008
[patent_app_country] => US
[patent_app_date] => 2020-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34568
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 202
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17110008
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/110008 | Benzamide and active compound compositions and methods of use | Dec 1, 2020 | Issued |
Array
(
[id] => 16883644
[patent_doc_number] => 20210169839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => PEDIATRIC IMMEDIATE-RELEASE FORMULATION OF THE POTASSIUM CHANNEL OPENER EZOGABINE
[patent_app_type] => utility
[patent_app_number] => 17/109937
[patent_app_country] => US
[patent_app_date] => 2020-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10262
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17109937
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/109937 | PEDIATRIC IMMEDIATE-RELEASE FORMULATION OF THE POTASSIUM CHANNEL OPENER EZOGABINE | Dec 1, 2020 | Abandoned |
Array
(
[id] => 19182082
[patent_doc_number] => 11988667
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-21
[patent_title] => Fluorescent compound and fluorescent labeled biological substance using the same
[patent_app_type] => utility
[patent_app_number] => 17/105638
[patent_app_country] => US
[patent_app_date] => 2020-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26312
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 500
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17105638
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/105638 | Fluorescent compound and fluorescent labeled biological substance using the same | Nov 26, 2020 | Issued |
Array
(
[id] => 20302399
[patent_doc_number] => 12448377
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-21
[patent_title] => Heterocyclic compound
[patent_app_type] => utility
[patent_app_number] => 17/780125
[patent_app_country] => US
[patent_app_date] => 2020-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25074
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17780125
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/780125 | Heterocyclic compound | Nov 25, 2020 | Issued |
Array
(
[id] => 18162371
[patent_doc_number] => 20230028964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => PREPARATION OF SUBSTITUTED AROMATIC CARBOXAMIDES
[patent_app_type] => utility
[patent_app_number] => 17/779262
[patent_app_country] => US
[patent_app_date] => 2020-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5779
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 598
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17779262
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/779262 | PREPARATION OF SUBSTITUTED AROMATIC CARBOXAMIDES | Nov 24, 2020 | Pending |
Array
(
[id] => 20438760
[patent_doc_number] => 12509587
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-30
[patent_title] => Crystal of indocyanine compound
[patent_app_type] => utility
[patent_app_number] => 17/780138
[patent_app_country] => US
[patent_app_date] => 2020-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 17
[patent_no_of_words] => 822
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17780138
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/780138 | Crystal of indocyanine compound | Nov 24, 2020 | Issued |
Array
(
[id] => 18289882
[patent_doc_number] => 11618744
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-04
[patent_title] => Benzoimidazoles as prolyl hydroxylase inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/103482
[patent_app_country] => US
[patent_app_date] => 2020-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46048
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 229
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17103482
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/103482 | Benzoimidazoles as prolyl hydroxylase inhibitors | Nov 23, 2020 | Issued |
Array
(
[id] => 18664824
[patent_doc_number] => 11771689
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-03
[patent_title] => Cereblon modulators and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/950697
[patent_app_country] => US
[patent_app_date] => 2020-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 22649
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 469
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16950697
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/950697 | Cereblon modulators and uses thereof | Nov 16, 2020 | Issued |
Array
(
[id] => 17697208
[patent_doc_number] => 11370920
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-28
[patent_title] => Fluorescent dyes and their uses as biomarkers
[patent_app_type] => utility
[patent_app_number] => 16/950705
[patent_app_country] => US
[patent_app_date] => 2020-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 18782
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 312
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16950705
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/950705 | Fluorescent dyes and their uses as biomarkers | Nov 16, 2020 | Issued |
Array
(
[id] => 18051580
[patent_doc_number] => 11524951
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-13
[patent_title] => 2-(2,4,5-substituted-anilino)pyrimidine compounds
[patent_app_type] => utility
[patent_app_number] => 17/096167
[patent_app_country] => US
[patent_app_date] => 2020-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 54673
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17096167
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/096167 | 2-(2,4,5-substituted-anilino)pyrimidine compounds | Nov 11, 2020 | Issued |
Array
(
[id] => 16673004
[patent_doc_number] => 20210061767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => NITROGEN RING LINKED DEOXYURIDINE TRIPHOSPHATASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/092123
[patent_app_country] => US
[patent_app_date] => 2020-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52111
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 201
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17092123
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/092123 | Nitrogen ring linked deoxyuridine triphosphatase inhibitors | Nov 5, 2020 | Issued |
Array
(
[id] => 18162108
[patent_doc_number] => 20230028700
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => CHIRAL GUANIDINES, SALTS THEREOF, METHODS OF MAKING CHIRAL GUANIDINES AND SALTS THEREOF, AND USES OF CHIRAL GUANIDINES AND SALTS THEREOF IN THE PREPARATION OF ENANTIOMERICALLY PURE AMINO ACIDS
[patent_app_type] => utility
[patent_app_number] => 17/773561
[patent_app_country] => US
[patent_app_date] => 2020-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13047
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 240
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17773561
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/773561 | CHIRAL GUANIDINES, SALTS THEREOF, METHODS OF MAKING CHIRAL GUANIDINES AND SALTS THEREOF, AND USES OF CHIRAL GUANIDINES AND SALTS THEREOF IN THE PREPARATION OF ENANTIOMERICALLY PURE AMINO ACIDS | Nov 1, 2020 | Pending |
Array
(
[id] => 18171726
[patent_doc_number] => 11571418
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-07
[patent_title] => Platinum compounds that inhibit constitutive STAT3 signaling and induce cell cycle arrest and apoptosis of malignant cells
[patent_app_type] => utility
[patent_app_number] => 17/077100
[patent_app_country] => US
[patent_app_date] => 2020-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 25
[patent_no_of_words] => 16789
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17077100
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/077100 | Platinum compounds that inhibit constitutive STAT3 signaling and induce cell cycle arrest and apoptosis of malignant cells | Oct 21, 2020 | Issued |
Array
(
[id] => 18537401
[patent_doc_number] => 20230242493
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => PROCESSES FOR MAKING TETRAZOLINONE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/766286
[patent_app_country] => US
[patent_app_date] => 2020-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6721
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17766286
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/766286 | PROCESSES FOR MAKING TETRAZOLINONE COMPOUNDS | Oct 19, 2020 | Pending |
Array
(
[id] => 17938348
[patent_doc_number] => 11472789
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-18
[patent_title] => Bicyclic carboxamides and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/070554
[patent_app_country] => US
[patent_app_date] => 2020-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 44938
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 452
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17070554
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/070554 | Bicyclic carboxamides and methods of use thereof | Oct 13, 2020 | Issued |
Array
(
[id] => 17938348
[patent_doc_number] => 11472789
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-18
[patent_title] => Bicyclic carboxamides and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/070554
[patent_app_country] => US
[patent_app_date] => 2020-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 44938
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 452
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17070554
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/070554 | Bicyclic carboxamides and methods of use thereof | Oct 13, 2020 | Issued |
Array
(
[id] => 17938348
[patent_doc_number] => 11472789
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-18
[patent_title] => Bicyclic carboxamides and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/070554
[patent_app_country] => US
[patent_app_date] => 2020-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 44938
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 452
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17070554
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/070554 | Bicyclic carboxamides and methods of use thereof | Oct 13, 2020 | Issued |
Array
(
[id] => 17938348
[patent_doc_number] => 11472789
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-18
[patent_title] => Bicyclic carboxamides and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/070554
[patent_app_country] => US
[patent_app_date] => 2020-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 44938
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 452
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17070554
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/070554 | Bicyclic carboxamides and methods of use thereof | Oct 13, 2020 | Issued |